Andrew MacLean

Dr. Andrew MacLean

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
GRGeeta Ramesh
Geeta Ramesh
AMAndrew MacLean
Andrew MacLean
MPMario T. Philipp
Mario T. Philipp
Cytokines and chemokines are proteins that coordinate the immune response throughout the body. The dysregulation of cytokines and chemokines is a central feature in the development of neuroinflammation, neurodegeneration, and demyelination both in the central and peripheral nervous systems and in conditions of neuropathic pain. Pathological states within the nervous system can lead to activation of microglia. The latter may mediate neuronal and glial cell injury and death through production of proinflammatory factors such as cytokines and chemokines. These then help to mobilize the adaptive immune response. Although inflammation may induce beneficial effects such as pathogen clearance and phagocytosis of apoptotic cells, uncontrolled inflammation can result in detrimental outcomes via the production of neurotoxic factors that exacerbate neurodegenerative pathology. In states of prolonged inflammation, continual activation and recruitment of effector cells can establish a feedback loop that perpetuates inflammation and ultimately results in neuronal injury. A critical balance between repair and proinflammatory factors determines the outcome of a neurodegenerative process. This review will focus on how cytokines and chemokines affect neuroinflammation and disease pathogenesis in bacterial meningitis and brain abscesses, Lyme neuroborreliosis, human immunodeficiency virus encephalitis, and neuropathic pain.

1 December 1999 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JYJ.D. Young
J.D. Young
ALA.J. Lawrence
A.J. Lawrence
AMAndrew MacLean
Andrew MacLean
BLB.P. Leung
B.P. Leung
IMI.B. McInnes
I.B. McInnes
RSR.D. Stevenson
R.D. Stevenson

1 January 2009 in Journal of NeuroVirology
Verified
Journal Article
Closed access
PDF file
NINathan S. Ivey
Nathan S. Ivey
AMAndrew MacLean
Andrew MacLean
ALAndrew A Lackner
Andrew A Lackner
The blood-brain barrier (BBB) plays a critical role in normal physiology of the central nervous system by regulating what reaches the brain from the periph

27 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
PMPietro Mancuso
Pietro Mancuso
CCChen Chen
Chen Chen
RKRafal Kaminski
Rafal Kaminski
JGJennifer Gordon
Jennifer Gordon
SLShuren Liao
Shuren Liao
KKKamel Khalili
Kamel Khalili
Elimination of HIV DNA from infected individuals remains a challenge in medicine. Here, we demonstrate that intravenous inoculation of SIV-infected macaques, a well-accepted non-human primate model of HIV infection, with adeno-associated virus 9 (AAV9)-CRISPR/Cas9 gene editing construct designed for eliminating proviral SIV DNA, leads to broad distribution of editing molecules and precise cleavage and removal of fragments of the integrated proviral DNA from the genome of infected blood cells and tissues known to be viral reservoirs including lymph nodes, spleen, bone marrow, and brain among others. Accordingly, AAV9-CRISPR treatment results in a reduction in the percent of proviral DNA in blood and tissues. These proof-of-concept observations offer a promising step toward the elimination of HIV reservoirs in the clinic.

7 March 2018 in mBio
Verified
Journal Article
Open access
RMRyan McNamara
Ryan McNamara
LCLindsey M. Costantini
Lindsey M. Costantini
TMT. Alix Myers
T. Alix Myers
BSBlake Schouest
Blake Schouest
NMNicholas J. Maness
Nicholas J. Maness
DDDirk P. Dittmer
Dirk P. Dittmer
Extracellular vesicles (EVs) or exosomes have been implicated in the pathophysiology of infections and cancer. The negative regulatory factor (Nef) encoded by simian immunodeficiency virus (SIV) and human immunodeficiency virus (HIV) plays a critical role in the progression to AIDS and impairs endosomal trafficking. Whether HIV-1 Nef can be loaded into EVs has been the subject of controversy, and nothing is known about the connection between SIV Nef and EVs. We find that both SIV and HIV-1 Nef proteins are present in affinity-purified EVs derived from cultured cells, as well as in EVs from SIV-infected macaques. Nef-positive EVs were functional, i.e., capable of membrane fusion and depositing their content into recipient cells. The EVs were able to transfer Nef into recipient cells. This suggests that Nef readily enters the exosome biogenesis pathway, whereas HIV virions are assembled at the plasma membrane. It suggests a novel mechanism by which lentiviruses can influence uninfected and uninfectable, i.e., CD4-negative, cells. IMPORTANCE Extracellular vesicles (EVs) transfer biologically active materials from one cell to another, either within the adjacent microenvironment or further removed. EVs also package viral RNAs, microRNAs, and proteins, which contributes to the pathophysiology of infection. In this report, we show that both human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) incorporate the virus-encoded Nef protein into EVs, including EVs circulating in the blood of SIV-infected macaques and that this presents a novel mechanism of Nef transfer to naive and even otherwise non-infectable cells. Nef is dispensable for viral replication but essential for AIDS progression in vivo . Demonstrating that Nef incorporation into EVs is conserved across species implicates EVs as novel mediators of the pathophysiology of HIV. It could help explain the biological effects that HIV has on CD4-negative cells and EVs could become biomarkers of disease progression.

1 July 2016 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
KRKatelyn N. Robillard
Katelyn N. Robillard
KLKim M. Lee
Kim M. Lee
KCKevin B. Chiu
Kevin B. Chiu
AMAndrew MacLean
Andrew MacLean